C

Cellectar Biosciences
D

CLRB

0.25110
USD
0.00
(1.17%)
مغلق
حجم التداول
3,908
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
11,570,657
أصول ذات صلة
A
ADVM
-0.02000
(-0.90%)
2.20000 USD
A
AGEN
0.04500
(1.19%)
3.82500 USD
A
ARWR
-0.250
(-1.62%)
15.140 USD
B
BPMC
1.130
(1.13%)
101.510 USD
C
CRBP
-0.15000
(-1.99%)
7.40000 USD
C
CVM
0.10000
(4.10%)
2.54000 USD
M
MNOV
-0.05000
(-3.52%)
1.37000 USD
المزيد
الأخبار المقالات

العنوان: Cellectar Biosciences

القطاع: Healthcare
الصناعة: Biotechnology
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.